ArticleJournal of translational medicine2025

Single-cell transcriptomics identifies PDIA4 as a marker of progression and therapeutic vulnerability in multiple myeloma.

Wenjie Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.